Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 21 (TBC1D21) is a Rab GTPase-activating protein highly expressed in male germ cells where it plays an essential structural role in sperm development. It is involved in the assembly of the mitochondrial sheath and axoneme during spermiogenesis, interacting with key mitochondrial proteins (such as TOMM20), cytoskeletal proteins (such as actin and tropomyosin TPM3), and dynein DNAH7 to ensure proper sperm tail formation and function. TBC1D21 acts as a scaffold protein needed for the organization and stabilization of the sperm mitochondrial sheath, and its deficiency leads to male infertility due to disrupted sperm motility and abnormal mitochondrial and axonemal structures. It does not appear to be a therapeutic target or druggable receptor, but lower TBC1D21 transcript levels are associated with poor sperm morphology in human infertility[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 21 (TBC1D21).